Prokidney (PROK) Assets Average (2021 - 2026)
Prokidney (PROK) reported Assets Average of $314.2 million for Q1 2026, down 25.83% year-over-year from $423.6 million in Q1 2025, and down 8.56% on a QoQ basis from $343.6 million in Q4 2025.
Prokidney (PROK) has 6 years of Assets Average data on file, last reported at $314.2 million in Q1 2026.
- Quarterly Assets Average fell 25.83% year-over-year to $314.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $314.2 million (down 25.83% YoY) and the FY2025 annual result came in at $388.3 million, down 9.86% from the prior year.
- Assets Average eased to $314.2 million in Q1 2026 per PROK's latest filing, from $343.6 million in the prior quarter.
- Across five years, Assets Average topped out at $525.2 million in Q4 2022 and bottomed at $145.5 million in Q1 2022.
- The 5-year median for Assets Average is $423.6 million (2025), against an average of $402.3 million.
- The widest annual swing landed in 2022, when Assets Average surged 260.06%; it then retreated 25.83% in 2026.
- Tracing PROK's Assets Average over 5 years: stood at $525.2 million in 2022, then retreated by 16.95% to $436.2 million in 2023, then grew by 4.99% to $457.9 million in 2024, then declined by 24.97% to $343.6 million in 2025, then declined by 8.56% to $314.2 million in 2026.
- Per Business Quant, the three latest PROK Assets Average figures stand at $314.2 million (Q1 2026), $343.6 million (Q4 2025), and $361.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Prokidney | 259.72 Mn | 1.55 Bn | - | 314.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 314.18 Mn |
| Dec 31, 2025 | 343.59 Mn |
| Sep 30, 2025 | 361.87 Mn |
| Jun 30, 2025 | 389.10 Mn |
| Mar 31, 2025 | 423.57 Mn |
| Dec 31, 2024 | 457.93 Mn |
| Sep 30, 2024 | 486.98 Mn |
| Jun 30, 2024 | 443.46 Mn |
| Mar 31, 2024 | 404.16 Mn |
| Dec 31, 2023 | 436.18 Mn |
| Sep 30, 2023 | 468.01 Mn |
| Jun 30, 2023 | 489.69 Mn |
| Mar 31, 2023 | 506.57 Mn |
| Dec 31, 2022 | 525.22 Mn |
| Sep 30, 2022 | 391.72 Mn |
| Jun 30, 2022 | 250.88 Mn |
| Mar 31, 2022 | 145.53 Mn |
| Dec 31, 2021 | 145.87 Mn |
| Sep 30, 2021 | 126.03 Mn |